RxDoctor Payments Data

Ronald Vincent, NP

Family · Farmington, MINPI 1851994008

Payments from drug & device makers

$2,806in general payments, 2019–2025

Across 158 payments — averaging $17.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AstraZeneca$441
  • Amgen$190
  • Lilly USA, LLC$183
  • Alk-abello, Inc$141
  • AbbVie$137
  • plus $666 from 12 others

What the payments were for

  • Food & beverage$2,806100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,806 in reported general payments places this provider in the 85th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Medicare billing

Part B allowed, 2024
$28,395
Medicare patients
132
Services billed
691

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide40$71,970
JardianceEmpagliflozin55$57,566
EliquisApixaban33$46,843
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$15,411
FarxigaDapagliflozin Propanediol12$13,422
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$3,215
Atorvastatin Calcium120$1,942
Rosuvastatin Calcium93$1,480
Azelastine Hcl58$1,114
Midodrine Hcl11$1,110
Albuterol Sulfate HfaAlbuterol Sulfate32$933
Metoprolol Succinate66$881
Losartan Potassium55$748
Lisinopril56$638
Olmesartan Medoxomil24$559

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,048$71,97040 claims
Boehringer IngelheimJardiance$105$57,56655 claims
PfizerEliquis$53$46,84333 claims
GSKTrelegy Ellipta$110$15,41111 claims
AstraZenecaFarxiga$441$13,42212 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$21$35324 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,657 family providers in Michigan.

Other family in Farmington

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →